Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

BACKGROUND: Limited prospective studies have examined changes in non-alcoholic fatty-liver disease (NAFLD) related serum-metabolites and none the effects of NAFLD-reversion. We aimed to evaluate whether perturbations in metabolites indicate predisposition to NAFLD development and to assess the effec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nutr Metab (Lond)
Autors principals: Papandreou, Christopher, Bullò, Mònica, Tinahones, Francisco José, Martínez-González, Miguel Ángel, Corella, Dolores, Fragkiadakis, Georgios A., López-Miranda, José, Estruch, Ramon, Fitó, Montserrat, Salas-Salvadó, Jordi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581927/
https://ncbi.nlm.nih.gov/pubmed/28878811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-017-0213-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars